|
|
| | Vodobatinib Basic information |
| Product Name: | Vodobatinib | | Synonyms: | 2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide;Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide;N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide;Vodobatinib;Vodobatinib (SCO-088, SUN-K706;Vodobatinib (K0706);myeloid,Inhibitor,inhibit,Vodobatinib,chronic,K0706,Bcr-Abl,K 0706,Bcr-Abl1,leukemia,TKI;2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide | | CAS: | 1388803-90-4 | | MF: | C27H20ClN3O2 | | MW: | 453.92 | | EINECS: | | | Product Categories: | | | Mol File: | 1388803-90-4.mol |  |
| | Vodobatinib Chemical Properties |
| Boiling point | 748.6±60.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 125 mg/mL (275.38 mM; Need ultrasonic) | | pka | 10.09±0.23(Predicted) |
| | Vodobatinib Usage And Synthesis |
| | Vodobatinib Preparation Products And Raw materials |
|